Guan, Q.; Aktar, S.J.; Pataky, R.E.; Stephen, M.M.; Marques, M.; Gambaro, K.; Rachedi, K.; Forster, K.; Strub, S.; Stock, D.;
et al. Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada. Curr. Oncol. 2024, 31, 3591-3602.
https://doi.org/10.3390/curroncol31060264
AMA Style
Guan Q, Aktar SJ, Pataky RE, Stephen MM, Marques M, Gambaro K, Rachedi K, Forster K, Strub S, Stock D,
et al. Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada. Current Oncology. 2024; 31(6):3591-3602.
https://doi.org/10.3390/curroncol31060264
Chicago/Turabian Style
Guan, Qi, Suriya J. Aktar, Reka E. Pataky, Mariet Mathew Stephen, Maud Marques, Karen Gambaro, Kahina Rachedi, Katharina Forster, Samara Strub, David Stock,
and et al. 2024. "Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada" Current Oncology 31, no. 6: 3591-3602.
https://doi.org/10.3390/curroncol31060264
APA Style
Guan, Q., Aktar, S. J., Pataky, R. E., Stephen, M. M., Marques, M., Gambaro, K., Rachedi, K., Forster, K., Strub, S., Stock, D., de Léséleuc, L., Cheung, W. Y., Peacock, S., Farrer, C., Gavura, S., Tadrous, M., Grant, R. C., & Chan, K. K. W.
(2024). Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada. Current Oncology, 31(6), 3591-3602.
https://doi.org/10.3390/curroncol31060264